Commonwealth Equity Services’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
35,950
-31,374
| -47% | -$97.7K | ﹤0.01% | 4046 |
|
|
2025
Q1 | $228K | Buy |
67,324
+1,294
| +2% | +$4.38K | ﹤0.01% | 3730 |
|
|
2024
Q4 | $374K | Sell |
66,030
-2,900
| -4% | -$16.4K | ﹤0.01% | 3219 |
|
|
2024
Q3 | $403K | Sell |
68,930
-8,975
| -12% | -$52.5K | ﹤0.01% | 3088 |
|
|
2024
Q2 | $616K | Buy |
77,905
+20,950
| +37% | +$166K | ﹤0.01% | 2659 |
|
|
2024
Q1 | $530K | Buy |
+56,955
| New | +$530K | ﹤0.01% | 2770 |
|
|
2023
Q2 | – | Sell |
-18,000
| Closed | -$138 | – | 3934 |
|
|
2023
Q1 | $138 | Sell |
18,000
-5,500
| -23% | -$42 | ﹤0.01% | 3431 |
|
|
2022
Q4 | $143K | Sell |
23,500
-834
| -3% | -$5.08K | ﹤0.01% | 3338 |
|
|
2022
Q3 | $144K | Hold |
24,334
| – | – | ﹤0.01% | 3293 |
|
|
2022
Q2 | $143K | Buy |
+24,334
| New | +$143K | ﹤0.01% | 3300 |
|
|
2019
Q2 | – | Sell |
-13,374
| Closed | -$255K | – | 2819 |
|
|
2019
Q1 | $255K | Buy |
13,374
+815
| +6% | +$15.5K | ﹤0.01% | 2284 |
|
|
2018
Q4 | $118K | Sell |
12,559
-2,013
| -14% | -$18.9K | ﹤0.01% | 2464 |
|
|
2018
Q3 | $275K | Sell |
14,572
-1,700
| -10% | -$32.1K | ﹤0.01% | 2245 |
|
|
2018
Q2 | $318K | Buy |
16,272
+3,500
| +27% | +$68.4K | ﹤0.01% | 2063 |
|
|
2018
Q1 | $239K | Sell |
12,772
-11
| -0.1% | -$206 | ﹤0.01% | 2256 |
|
|
2017
Q4 | $212K | Buy |
+12,783
| New | +$212K | ﹤0.01% | 2324 |
|